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Methods for site-speciﬁc modiﬁcation of proteins remain in high
demand. The transpeptidation reaction catalyzed by sortase A from
Staphylococcus aureus (SrtAstaph) allows site-speciﬁc derivatization
of proteins with virtually any type of functional material.
1 Target
proteins are engineered to contain the SrtAstaph recognition site
(LPXTG) near their C terminus, thus allowing a transacylation
reaction in which the residues C-terminal to threonine are exchanged
for a synthetic oligoglycine peptide (Scheme 1). While the range
of applications for this technology has expanded considerably,
1 the
ligation chemistry itself has seen relatively few modiﬁcations or
improvements. Since nearly all Gram-positive bacteria possess
sortases, many with reactivity distinct from SrtAstaph, there is an
exciting opportunity to develop complementary strategies for protein
engineering using other members of this enzyme family.
2,3 Here
we present a strategy for placing discrete labels at both termini in
the same polypeptide through the use of multiple sortases. We ﬁrst
describe the ability of SrtAstaph to append labels at the protein N
terminus and then demonstrate how this can be used in conjunction
with the activity of sortase A from Streptococcus pyogenes (SrtAstrep)
to yield dual-labeled proteins.
With regard to N-terminal labeling mediated by SrtAstaph,w e
reasoned that labeled synthetic peptides containing the LPXTG
recognition motif, or structural analogues thereof, could generate
the requisite acyl-enzyme intermediate necessary for transpepti-
dation. In combination with protein nucleophiles containing one
or more N-terminal glycines, this should result in transfer of the
label to the protein N terminus (Figure 1a). We synthesized FITC
(1) and biotin (2) derivatives of an LPRT peptide in which the
glycine of the normal LPXTG motif was replaced by a methyl ester
(Figure 1b and Figure S1 in the Supporting Information). The use
of an ester derivative rather than the entire LPXTG motif was
motivated by our concern that the glycine residue released after
LPXTG cleavage might compete with the protein nucleophile,
potentially complicating the desired N-terminal-labeling reaction.
In contrast, transacylation with 1 and 2 would generate MeOH, a
poor nucleophile for transacylation compared with glycine. It should
be noted that concurrently with the work described here, it was
demonstrated that labeled LPETGG peptides are viable tools for
N-terminal labeling using SrtAstaph.
4
With 1 and 2 in hand, we expressed a series of model proteins
containing N-terminal glycine residues. We prepared variants of
the cholera toxin B subunit (CtxB) with one, three, or ﬁve
N-terminal glycines. In order to verify the selectivity for glycine,
we prepared a control construct containing an N-terminal alanine
residue. In the presence of SrtAstaph, we observed robust labeling
of G3-CtxB and G5-CtxB using 500 µM 1 f o r2ha t3 7°C, with no
apparent labeling of the alanine-containing control (Figure 1c).
Electrospray ionization mass spectrometry (ESI-MS) revealed
quantitative labeling of G3-CtxB and G5-CtxB, with no modiﬁcation
observed for G1-CtxB and AG4-CtxB (Figure S2). Similar experi-
ments with biotinylated derivative 2 and G5-CtxB yielded compa-
rable results, as veriﬁed by ESI-MS and streptavidin immunoblot
(Figure S3). In all cases, residual labeling of SrtAstaph itself,
attributable to the formation of a covalent acyl-enzyme intermedi-
ate, was detected. N-terminal transpeptidation was also successful
for two additional protein substrates, eGFP with ﬁve N-terminal
glycines and UCHL3 containing a single N-terminal glycine (Figure
S4).
With the ability of SrtAstaph to append labels at either terminus,
we pursued the possibility of installing two modiﬁcations within
Scheme 1. C-terminal Labeling Using SrtAstaph
Figure 1. N-terminal labeling using SrtAstaph. (a) SrtAstaph catalyzes a
transacylation reaction using labeled LPRT methyl esters as substrates. The
labeled LPRT fragment is transferred to proteins containing N-terminal
glycines in a site-speciﬁc fashion. (b) FITC (1) and biotin (2) LPRT methyl
esters for N-terminal transacylation. (c) CtxB derivatives (50 µM) were
treated with 500 µM 1 and 50 µM SrtAstaph f o r2ha t3 7°C in 50 mM Tris
(pH 7.5), 150 mM NaCl, and 10 mM CaCl2. Reactions were analyzed by
SDS-PAGE with visualization by coomassie staining and ﬂuorescent gel
scanning.
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using SrtAstaph alone were unsuccessful, as intramolecular transpep-
tidation between N-terminal glycines and the C-terminal LPXTG
motif was unavoidable in most cases. Therefore, we considered
the possibility of using a second, distinct sortase, an idea that has
been suggested but never reduced to practice.
1,5 We initially sought
to use sortase B (SrtB) from either Staph. aureus or Bacillus
anthracis as enzymes with recognition sequences (NPQTN and
NPKTG, respectively) orthogonal to that of SrtAstaph.
6,7 Both SrtB
enzymes were easily produced in Escherichia coli and puriﬁed to
homogeneity. We reproduced the reported in vitro enzyme activity
using a FRET-based assay to measure cleavage of short peptides
substrates.
6,7 However, to date we have failed to obtain transpep-
tidation with either SrtB on protein substrates modiﬁed with the
appropriate recognition sequences on a time scale or with yields
that compare favorably with SrtAstaph (data not shown).
We ultimately arrived at a successful orthogonal strategy using
SrtAstrep, which recognizes the same LPXTG sequence used by
SrtAstaph but can accept alanine-based nucleophiles.
8 This leads to
the formation of an LPXTA sequence at the site of ligation, a motif
refractory to cleavage by SrtAstaph.
9 This allows SrtAstaph to act on
the N terminus without affecting the C-terminal modiﬁcation
installed with SrtAstrep.
Our ﬁnal strategy for dual-terminus labeling is outlined in Figure
2b. We ﬁrst synthesized a tetramethylrhodamine-labeled peptide
(3) containing two N-terminal alanine residues to serve as the
nucleophile for SrtAstrep-mediated protein ligation (Figure 2a and
Figure S5). We prepared two model substrates (eGFP and UCHL3)
containing masked N-terminal glycines that are exposed only upon
thrombin cleavage. Masking was required because SrtAstrep was
observed to ligate both glycine and alanine nucleophiles (data not
shown). Substrates also contained an LPXTG motif at the C
terminus to allow a ﬁrst round of labeling with SrtAstrep. For both
eGFP and UCHL3, C-terminal labeling using 3 and SrtAstrep resulted
in >90% conversion to the desired adduct, as revealed by ESI-MS
(Figure S6). SrtAstrep was quenched by the addition of MTSET
followed by removal of His6-tagged SrtAstrep using Ni-NTA.
Residual 3 was then removed using a disposable desalting column.
Thrombin cleavage proceeded in quantitative fashion using com-
mercial thrombin agarose resin (Figure S6). The exposed N-terminal
glycines were then labeled by treatment with 500 µM 1 and 50
µM ∆59-SrtAstaph
10 for ∼1ha t3 7°C. ESI-MS of crude reaction
mixtures showed the dual-labeled material as the major component,
with only minor amounts of byproduct (Figure S6). A ﬁnal
separation by anion-exchange chromatography yielded dual-labeled
eGFP and UCHL3 with excellent purity, as determined by both
SDS-PAGE and ESI-MS (Figure 2c,d and Figure S6). In the case
of UCHL3, we observed some additional low-intensity bands in
the ﬂuorescent gel scan (Figure 2d). However, quantitative densi-
tometric analysis of coomassie-stained gels indicated purity in
excess of 95% for both dual-labeled eGFP and UCHL3.
In summary, we have developed a strategy for placing different
chemical labels at the two ends of the same polypeptide using two
sortase enzymes with unique reactivities. We anticipate that this
method will be applicable to the preparation of protein conjugates
for refolding studies or for the construction of protein sensors, where
measuring conformational changes by FRET is a common mode
of detection. In more general terms, this work begins to explore
the range of protein modiﬁcations that can be accessed using
alternative sortases. The number of sortases that have been produced
in recombinant form with retention of activity is continually
increasing, and we are exploring the use of these unique enzymes
as tools for protein engineering.
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Figure 2. Site-speciﬁc N- and C-terminal labeling using multiple sortases.
(a) Tetramethylrhodamine-labeled dialanine nucleophile (3) for SrtAstrep-
mediated transpeptidation. (b) Strategy for the installation of discrete labels
at both termini of the same protein using ∆59-SrtAstaph and SrtAstrep. (c, d)
SDS-PAGE characterization with ﬂuorescent gel scanning of dual-labeled
(c) eGFP and (d) UCHL3.
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